Cargando…
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
OBJECTIVE: Inflammation has emerged as a new treatment target in patients with coronary artery disease and inflammation seems to play an important role in ischaemia/reperfusion injury that follows ST-elevation myocardial infarction (STEMI). We aimed to explore the role of acute and sustained interle...
Autores principales: | Tøllefsen, Ingvild Maria, Shetelig, Christian, Seljeflot, Ingebjørg, Eritsland, Jan, Hoffmann, Pavel, Andersen, Geir Øystein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693166/ https://www.ncbi.nlm.nih.gov/pubmed/34933964 http://dx.doi.org/10.1136/openhrt-2021-001869 |
Ejemplares similares
-
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
por: Helseth, Ragnhild, et al.
Publicado: (2019) -
Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI
por: Feistritzer, Hans-Josef, et al.
Publicado: (2015) -
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021) -
Localising culprit artery in inferior STEMI
por: Farhat-Sabet, Ardalon, et al.
Publicado: (2023) -
Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)